Clinical Trial Update: Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB) [Phase 2]

View source ↗

Summary

ClinicalTrials.gov entry for a Phase 2 dose-ranging study of nebulized CSL787 in adults with Non-cystic Fibrosis Bronchiectasis. The trial aims to assess effica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• CSL787

Snippet

Sponsor: CSL Behring | Conditions: Non-cystic Fibrosis Bronchiectasis | Phase 2 | Status: RECRUITING